Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Gaitianli Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development, manufacturing, and sale of over-the-counter (OTC) medicines and health supplements. The company is most famous for its Gaitianli brand of calcium supplements, which became a household name in China for treating calcium deficiency and osteoporosis. Its product portfolio includes treatments for the common cold, respiratory ailments, and nutritional deficiencies. Since its acquisition by the Xiuzheng Pharmaceutical Group in 2006, Gaitianli has integrated its production capabilities into one of China's largest private pharmaceutical networks. The company maintains a strong focus on traditional Chinese medicine (TCM) combined with modern pharmacological standards to serve the domestic consumer health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaitianli.